Multiple Sclerosis
Group leader
Luisa María Villar Guimerans
luisamaria.villar(ELIMINAR)@salud.madrid.org
Tlf.: 0034 913368029
Principal Investigator
- Enric Monreal Laguillo
- Juan Luis Chico Garcia
- José Ignacio Fernández Velasco
Collaborating Staff
- María Mercedes Espiño Martínez
- Ernesto Roldán Santiago
- Lucienne Costa-Frossard França
- Susana Sainz de la Maza Cantero
- Noelia Villarrubia Migallón
- Roberto Pariente Rodríguez
- Alexander Rodero Romero
- Fernando Rodríguez Jorge
- José Luis Veiga González
- Eulalia Rodríguez Martín
- Zahara Garcia de Castro
- Cristina Saavedra Pérez
- Marta Selva Giménez
- Marina Pérez Pleite
- Enrique García Barrera
Group leader
Luisa María Villar Guimerans
luisamaria.villar(ELIMINAR)@salud.madrid.org
Tlf.: 0034 913368029
Principal Investigator
- Enric Monreal Laguillo
- Juan Luis Chico Garcia
- José Ignacio Fernández Velasco
Collaborating Staff
- María Mercedes Espiño Martínez
- Ernesto Roldán Santiago
- Lucienne Costa-Frossard França
- Susana Sainz de la Maza Cantero
- Noelia Villarrubia Migallón
- Roberto Pariente Rodríguez
- Alexander Rodero Romero
- Fernando Rodríguez Jorge
- José Luis Veiga González
- Eulalia Rodríguez Martín
- Zahara Garcia de Castro
- Cristina Saavedra Pérez
- Marta Selva Giménez
- Marina Pérez Pleite
- Enrique García Barrera
Strategic Objectives
- To delve deeper into the study of the pathophysiological mechanisms of MS.
- To study the mechanisms associated with the progressive forms of the disease.
- To identify immunological factors that predict the early risk of MS progression in order to establish personalized therapy for this disease.
- To evaluate biomarkers of treatment response and identify patients at risk of serious side effects.
- To study modifiable environmental factors that play a role in the course of the disease.
Research Lines
- Study of the pathological mechanisms in MS.
- Search for biomarkers that identify the best benefit/risk profile for different biological therapies in MS.
- Search for biomarkers that identify the risk of progression in MS.
- Immunological mechanisms associated with primarily progressive forms of MS.
- Association of antibodies against the Epstein-Barr virus and the clinical and immunological phenotype in MS.
Location
Ramón y Cajal University Hospital
Laboratory: Immunology Department, Floor -1, Left
Clinical Unit: Neurology Department, Floor -2, Center
Keywords
Multiple Sclerosis (MS), biomarkers, immunological mechanisms, B cells, antibodies